by Rene van den Wijngaard
Long-term treatment of functional dyspepsia with proton-pump inhibitors can alter the gut microbiome. A new pilot randomized, double-blind, placebo-controlled trial suggests the potential of spore-forming probiotics in patients with functional dyspepsia.
Gluten is not the only culprit in unwanted intestinal and extra-intestinal symptoms among non-celiac individuals. Recently, the herbicide glyphosate, present in residual amounts in foods, has received a lot of attention when it comes to digestive and overall health.
by GMFH Editing Team
A clear consensus on the mechanisms of action of food intolerances doesn’t exist due to their heterogeneous nature. A new narrative review sheds light on the scientific background of the mechanisms, diagnosis and management of food intolerances.
by Numan Oezguen, James Versalovic
An accurate diagnosis of patients with IBS remains a challenge because it relies largely on clinical criteria. Now scientists have developed an improved disease classification technique that enables personalized diagnosis of pediatric patients with IBS based on their gut microbiome.
by GMFH Editing Team
Dietary fibers may benefit gut bacterial groups in different ways. Hiel and colleagues have recently found that regular consumption of vegetables rich in inulin-type fructans may improve food behavior, including a drop in preference for fat, salt or sugars.
by GMFH Editing Team
In this video, the European Society of Neurogastroenterology & Motility (ESNM) explains how important it is for irritable bowel syndrome (IBS) to be diagnosed so it can then be treated correctly.
by GMFH Editing Team
Small intestinal bacterial overgrowth has been involved in symptoms linked to functional gastrointestinal disorders. Purna C. Kashyap and colleagues show that the small intestinal microbiome is altered in patients with gastrointestinal symptoms, which can be triggered through diet in a microbiota-dependent manner.
Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders, affecting more than 10% of the population, with the highest impact in women. Although its origin is still unknown, reduced gut microbial diversity could be involved in its development.
